Prostate Cancer Current Events | Prostate Cancer News | 3
|
| Page
3 of
99 |
1973 Results |
|
|
|
Sort By:
Page Views | Date |
Pros, cons of drug proven to prevent prostate cancer should be considered, researchers recommend
Findings by UT Southwestern Medical Center researchers encourage men to weigh both the potential benefits and side effects of the drug finasteride before taking it to prevent prostate cancer. view more (2008-01-21)
MRI findings help forecast prostate cancer prognosis
Magnetic resonance imaging (MRI) findings in patients about to undergo radiation therapy for prostate cancer can help predict the likelihood that the cancer will return and spread post-treatment, according to a new study published in the April issue of the journal Radiology. view more (2008-03-25)
Genetic marker may predict early onset of prostate cancer
Fox Chase Cancer Center researchers have identified a genetic marker that is associated with an earlier onset of prostate cancer in Caucasian men who have a family history of prostate cancer. view more (2009-05-18)
Preventium is 'where the prevention of breast and prostate cancer begins'
Dr. Ercole Cavalieri and Dr. Eleanor Rogen of the University of Nebraska Medical Center, Eppley Institute for Research in Cancer, located in Omaha, Nebraska, have identified the triggering mechanism by which breast and prostate cancer cells begin. view more (2009-03-17)
Speed of PSA rise helps predict survival for prostate cancer patients
The clinical outcome for prostate cancer patients who have been treated with hormone therapy and radiation therapy can usually be determined by how rapidly their prostate specific antigen level rises following treatment. view more (2005-10-03)
PSA doubling predicts prostate cancer recurrence
A detectable level of prostate-specific antigen (PSA) is the first indicator of recurrent prostate cancer after radical prostatectomy. In a new Mayo Clinic study, the concept of PSA doubling time (DT) is found to be a reliable tool to distinguish which patients have prolonged innocuous PSA levels after therapy from those who are at great risk for... view more... (2007-04-10)
PSA is poor predictor of lethal prostate cancer
The amount of prostate-specific antigen (PSA) in a man's bloodstream at the time of his prostate cancer diagnosis or its rate of change over the course of the disease does not adequately predict lethal prostate cancer. view more (2007-04-04)
Drug reverses bone loss in men with prostate cancer during the first year of treatment
A common type of treatment used to protect bone density in menopausal women is also an effective therapy for advanced prostate cancer patients during the first year of hormone therapy. view more (2006-02-27)
Study shows that prostate cancer increases the risk of bone fracture
As unlikely as it sounds, scientists at the Garvan Institute for Medical Research have shown that there is a link between prostate cancer and a higher risk of bone fracture. view more (2008-05-14)
New gene test for prostate cancer at hand
Men with susceptibility for prostate cancer will soon be identifiable through a simple DNA test. So hope scientists at the Swedish medical university Karolinska Institutet, who have shown that men carrying a combination of known risk genes run a four to five times higher risk of developing prostate cancer. view more (2008-01-18)
Faulty gene linked to prostate cancer risk
Missing sections of a gene, which programmes the manufacture of a chemical to alert the body to DNA damage. view more (2006-10-31)
Flower power may bring ray of sunshine to cancer sufferers
A mini-protein found in sunflower seeds could be the key to stopping tumors spreading in prostate cancer patients, according to QUT researchers. view more (2008-05-01)
New advance in prostate cancer management
Scientists from The Institute of Cancer Research have developed a technique which will markedly help in predicting the behaviour of prostate cancer. view more (2005-08-10)
Antioxidant supplementation not associated with decreased risk of prostate cancer
Intakes of dietary or supplemental antioxidants were not associated with a decreased risk of prostate cancer among men in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. view more (2006-02-15)
Anti-inflammatory drugs may mask prostate cancer marker
Regular use of nonsteroidal anti-inflammatory drugs (NSAIDs), such as aspirin and ibuprofen, may reduce serum levels of the prostate biomarker, PSA (prostate specific antigen), and hence may alter the detection of prostate cancer in individuals who take these medications. view more (2008-09-08)
Possible link found between x-rays and prostate cancer
Researchers at The University of Nottingham have shown an association between certain past diagnostic radiation procedures and an increased risk of young-onset prostate cancer - a rare form of prostate cancer which affects about 10 per cent of all men diagnosed with the disease. view more (2008-07-16)
Should the UK lower the age for prostate cancer detection?
Prostate cancer screening occurs in many countries ahead of evidence from ongoing trials. In many countries, early detection (including the UK, when practised), and opportunistic screening commences at 50 years, but a lower age limit has recently been adopted in the USA based on two studies that found elevated prostate specific antigen (PSA)... view more... (2007-11-16)
Research reveals molecular pathway behind invasive prostate cancers
University of Cincinnati (UC) cancer and cell biologists have identified a new molecular pathway key to the development of invasive prostate cancers. view more (2009-05-19)
Online tool supports more dialogue on prostate cancer risk
A comprehensive, clinical nomogram tool, the Sunnybrook Prostate Cancer Risk Calculator - the first to use all known risk factors for prostate cancer - is available online to help men determine individual prostate cancer risk in consultation with their primary care physician. view more (2008-02-05)
Standard treatment for prostate cancer may encourage spread of disease
A popular prostate cancer treatment called androgen deprivation therapy may encourage prostate cancer cells to produce a protein that makes them more likely to spread throughout the body, a new study by Johns Hopkins researchers suggests. view more (2007-10-01)
|
|
| Page
3 of
99 |
1973 Results |
|
|
|
Sort By:
Page Views | Date |
|
